JM PHARMA CONSULTING LTD

Company number 08774310 · Active (Active - Proposal to Strike off)

JM PHARMA CONSULTING LTD is a private limited company registered in MAIDSTONE, United Kingdom, incorporated on 14 Nov 2013. Its registered activity is other business support service activities n.e.c.. Its latest published accounts for the period ending 30 Nov 2025 show equity of £1, total assets of £1. It has filed 7 sets of accounts, 5 of them after the deadline. Our model estimates a 0.01 % probability that it becomes insolvent within 12 months, 0.1 times the average for active companies (low risk).

Insolvency risk, next 12 months

0.01 %
Low risk
Lowest riskHighest risk

Higher than 82 % of active companies in the United Kingdom. 0.1× the average annual insolvency rate (0.12 %).

Raises the risk

Share of filings late3.6×≥ 0.666667 · 0.42 % became insolvent
Late filings2.5×≥ 2 · 0.29 % became insolvent
Industry1.7×82 · 0.19 % became insolvent
Equity change ÷ assets1.6×< -0.688951 · 0.19 % became insolvent
Company age (years)1.6×6.256–12.986 · 0.18 % became insolvent
Has filed accounts1.3×1 · 0.16 % became insolvent

Lowers the risk

Accounts type0.1×dormant · 0.01 % became insolvent
Current liabilities ÷ assets0.3×< 0.010552 · 0.03 % became insolvent
Total assets (log)0.3×< 2.87772 · 0.03 % became insolvent
Accounts filed0.3×≥ 6 · 0.04 % became insolvent
Employees0.4×0–1 · 0.05 % became insolvent
Filing delay of last accounts (days)0.5×< 76 · 0.05 % became insolvent

Each factor compares companies in the same group (for example the same age band) with the average. The score is a statistical estimate from public data (model AUC 0.99, trained 8 Nov 2026), not a credit rating. How it works.

Company details

Company number
08774310 · official register
Status
Active - Proposal to Strike off
Legal form
Private Limited Company
Incorporated
14 Nov 2013 (13 years)
Registered address
ME14 1FY MAIDSTONE
Postcode area
Rochester
Activity
82990 Other business support service activities n.e.c.
Industry
Office administrative and business support
Accounts overdue
No

Insolvency and register events

No insolvency or liquidation events on record.

Annual accounts GBP

Period endPublishedTurnoverResultEquityTotal assetsCurrent liabilitiesCashEmployees
30 Nov 202515 Dec 2025– –£1£1 £0–0
30 Nov 202415 Jul 2025– –£10– –£10–
30 Nov 202315 Jul 2025– –£10– –£10–
30 Nov 202215 Jul 2025– –£10– –£10–
30 Nov 202115 Jul 2025– –£10– –£10–
30 Nov 202015 Feb 2022– –£5,602£22k £16k–1
30 Nov 201915 Jan 2021– –£26k£62k £37k–1

As published. Small companies often file a balance sheet only, so turnover and result can be missing.

Similar companies in Rochester

Questions about JM PHARMA CONSULTING LTD

What is the company number of JM PHARMA CONSULTING LTD?

JM PHARMA CONSULTING LTD is registered under company number 08774310 in the official register of United Kingdom. View it at the official register.

Is JM PHARMA CONSULTING LTD still active?

Yes. JM PHARMA CONSULTING LTD is registered as active (status: Active - Proposal to Strike off).

Has JM PHARMA CONSULTING LTD gone bankrupt or into insolvency?

No insolvency, bankruptcy or administration is recorded for JM PHARMA CONSULTING LTD in the official data.

How likely is JM PHARMA CONSULTING LTD to become insolvent?

Our model estimates a 0.01 % probability that JM PHARMA CONSULTING LTD becomes insolvent within the next 12 months (low risk). That is higher than 82 % of active companies in the United Kingdom.

When was JM PHARMA CONSULTING LTD founded?

JM PHARMA CONSULTING LTD was incorporated on 14 Nov 2013.

Where is JM PHARMA CONSULTING LTD registered?

JM PHARMA CONSULTING LTD's registered address is in ME14 1FY MAIDSTONE (Rochester), United Kingdom.

What do the latest accounts of JM PHARMA CONSULTING LTD show?

The latest published accounts (period ending 30 Nov 2025) show equity of £1, total assets of £1, 0 employees.

Data: Companies House – Free Company Data Product, Accounts Data Product, Public Data API (Contains public sector information licensed under the Open Government Licence v3.0.). Last updated 8 Nov 2026.